COVID-19 Medication Lot Recalled Nationwide Following Glass Particle Contamination
By Naveen Athrappully Gilead Sciences announced the voluntary recall of COVID-19 antiviral medication Veklury (remdesivir) after finding the presence of a glass particle in one of the medicine vials. After receiving a customer complaint, the company investigated the incident and confirmed the presence of the particle, according to a recall notice published on Sept. 20 by the U.S.
More Stories
StockNews.com Upgrades Littelfuse (NASDAQ:LFUS) to Buy
Littelfuse (NASDAQ:LFUS – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a...
Q2 2025 Earnings Forecast for Silvercorp Metals Inc. Issued By Raymond James (NYSEAMERICAN:SVM)
Silvercorp Metals Inc. (NYSEAMERICAN:SVM – Free Report) – Equities researchers at Raymond James lifted their Q2 2025 earnings per share...
Comparing GeneLink (OTCMKTS:GNLKQ) and Aclarion (NASDAQ:ACON)
Aclarion (NASDAQ:ACON – Get Free Report) and GeneLink (OTCMKTS:GNLKQ – Get Free Report) are both medical companies, but which is...
Popular (NASDAQ:BPOP) & Bank of New York Mellon (NYSE:BK) Head to Head Contrast
Bank of New York Mellon (NYSE:BK – Get Free Report) and Popular (NASDAQ:BPOP – Get Free Report) are both finance...
Short Interest in ENN Energy Holdings Limited (OTCMKTS:XNGSY) Increases By 550.0%
ENN Energy Holdings Limited (OTCMKTS:XNGSY – Get Free Report) saw a large growth in short interest during the month of...
DTE Energy (NYSE:DTE) vs. ReNew Energy Global (NASDAQ:RNW) Financial Analysis
ReNew Energy Global (NASDAQ:RNW – Get Free Report) and DTE Energy (NYSE:DTE – Get Free Report) are both oils/energy companies,...